Search research articles
Contact Us
Filters
Showing results (701-710 of 719) with videos related to
Page
of 72
Sort By:
British Journal of Pharmacology
|
December 8, 2017
Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABA<sub>A</sub> receptor positive allosteric modulator PF-06372865
Sarah A Nickolls, Rachel Gurrell, Guido van Amerongen, et al.
Nature Neuroscience
|
May 18, 2000
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype
R M McKernan, T W Rosahl, D S Reynolds, et al.
JAMA Network Open
|
October 6, 2025
A Surgical Handover System for Patient Physiology and Safety
Jessica M Ryan, Therese M Lynn, Dara O Kavanagh, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 18, 2005
Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines
Rebecca Dias, Wayne F A Sheppard, Rosa L Fradley, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2013
Evaluation of various static in vitro-in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drug
Md L T Vieira, B Kirby, I Ragueneau-Majlessi, et al.
Journal of Medicinal Chemistry
|
February 17, 2006
Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety
Michael G N Russell, Robert W Carling, Leslie J Street, et al.
Nature
|
March 3, 2017
The response of relativistic outflowing gas to the inner accretion disk of a black hole
Michael L Parker, Ciro Pinto, Andrew C Fabian, et al.
Alimentary Pharmacology & Therapeutics
|
October 7, 2014
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
N A Kennedy, R Kalla, B Warner, et al.
JCI Insight
|
November 3, 2018
Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms
J Humberto Treviño-Villarreal, Justin S Reynolds, Alexander Bartelt, et al.
Experimental Astronomy
|
March 14, 2023
A Case for Electron-Astrophysics
Daniel Verscharen, Robert T Wicks, Olga Alexandrova, et al.
Page
of 72
Search research articles
Search
Showing results (701-710 of 719) with videos related to
Sort By:
Page
of 72
British Journal of Pharmacology
|
December 8, 2017
Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABA<sub>A</sub> receptor positive allosteric modulator PF-06372865
Sarah A Nickolls, Rachel Gurrell, Guido van Amerongen, et al.
Nature Neuroscience
|
May 18, 2000
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype
R M McKernan, T W Rosahl, D S Reynolds, et al.
JAMA Network Open
|
October 6, 2025
A Surgical Handover System for Patient Physiology and Safety
Jessica M Ryan, Therese M Lynn, Dara O Kavanagh, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 18, 2005
Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines
Rebecca Dias, Wayne F A Sheppard, Rosa L Fradley, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2013
Evaluation of various static in vitro-in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drug
Md L T Vieira, B Kirby, I Ragueneau-Majlessi, et al.
Journal of Medicinal Chemistry
|
February 17, 2006
Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety
Michael G N Russell, Robert W Carling, Leslie J Street, et al.
Nature
|
March 3, 2017
The response of relativistic outflowing gas to the inner accretion disk of a black hole
Michael L Parker, Ciro Pinto, Andrew C Fabian, et al.
Alimentary Pharmacology & Therapeutics
|
October 7, 2014
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
N A Kennedy, R Kalla, B Warner, et al.
JCI Insight
|
November 3, 2018
Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms
J Humberto Treviño-Villarreal, Justin S Reynolds, Alexander Bartelt, et al.
Experimental Astronomy
|
March 14, 2023
A Case for Electron-Astrophysics
Daniel Verscharen, Robert T Wicks, Olga Alexandrova, et al.
Page
of 72